Sr. Scientist – Translational Medicine (M/F)

November 16th 2020

iTeos Therapeutics is a publicly-held (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing next generation immunotherapies. Based in Gosselies, Belgium and Cambridge, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute (UCLouvain) in 2011. In March 2020, the Company completed a $125 million Series B2 financing, and in July 2020, we completed our IPO raising over $200 million of proceeds. This additional capital will allow us to continue to develop our clinical pipeline and maintain our investments in our discovery research team to leverage its fantastic science to improve the lives of cancer patients. For more information, please visit

Mission Description

  • Actively participate and lead the definition, development and implementation of biomarker strategies for diverse projects in close interaction with the members of the project team(s).
  • Manage the selection, development, qualification/validation of clinically applicable biomarker assays including pharmacodynamic, predictive, prognostic, and safety biomarkers internally and/or in external analytical laboratories. 
  • Ensure the feasibility of such assays in a clinical setting and support their implementation in clinical trials. This includes the review of dedicated sections of clinical documents and other material needed, and requires a close interaction with the Clinical teams and external service providers.
  • Oversee pharmacodynamic and patient selection biomarker testing and complex data analysis across functional area. Mentor the experimental work of research assistant(s) and/or scientist(s).
  • Participate to experimental work to facilitate and assist with biomarker assay development and/or qualification.

Candidate profile


  • PhD, MD/PhD in Cancer Biology, Immunology, Cell, or Molecular Biology with a minimum of 5 years of relevant post-doctoral research experience in analyzing human samples and/or monitoring analysis of biological markers during clinical trials. Must have expertise in oncology or immunology.
  • Experience with the discovery, characterization, clinical application of biomarkers using flow cytometry, proteomics, molecular biology or immunohistochemistry of human tissue specimens.
  • Direct experience in qualification/validation, development, and outsourcing of clinically applicable pharmacodynamic biomarker assays.
  • Experience in implementing bio-assays in clinical studies.
  • Strong motivation, attention to details.


  • Fluent in English (oral and written). French is a plus.
  • Solution-oriented.  
  • Strong project and interpersonal skills.
  • Strongly organized and rigorous, you have a good ability to adapt to changes in priorities and to work effectively on multiple immune oncology programs in a fast paced environment
  • Although autonomous, you have a high ability to collaborate with internal and external stakeholders.


  • A stimulating position within a high-potential innovative biotech company.
  • The opportunity to work in a science-driven, dynamic, human‐sized, respectful and professional environment.
  • A challenging scientific and business growth in which you get to bring your knowledge and skills.
  • A permanent contract with an attractive salary package in line with the position responsibilities and your experience.

Contact Details

Send your CV together with an adapted cover letter to the following address : Please mention the reference SS-TM in the mail object.